Monopar Therapeutics Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Monopar Therapeutics Inc. (MNPR) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $3.20 million as of 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2021-05-13
- 2021-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $3.20M.
- 2020-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $1.80M.
- 2020-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $2.10M.
- 2020-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $3.00M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2021-03-31 | $3.20M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $1.80M 10-K · filed 2021-03-25 |
| 2020-09-30 | $2.10M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $3.00M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $3.40M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $13.00M 10-K · filed 2020-03-27 |
| 2019-09-30 | $1.50M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $700.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $800.00K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $900.00K 10-K · filed 2019-02-26 |
| 2018-09-30 | $100.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $600.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $800.00K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $925.13K 10-K · filed 2018-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |